Keryx Biopharmaceuticals (KERX) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free kerx Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCaliway Biopharmaceuticals Co Ltd 6919morningstar.com - April 13 at 11:07 PMXTL Biopharmaceuticals Ltd ADR XTLBmorningstar.com - November 15 at 11:50 PMImmuneOnco Biopharmaceuticals Shanghai Inc (1541)investing.com - September 11 at 3:35 PMQ2 2023 Westrock Coffee Co Earnings Callfinance.yahoo.com - August 13 at 5:45 PMKeryx CEO vs. a Short-Seller: Zerenex Patent Debatethestreet.com - July 29 at 11:12 PM8-K: CUTERA INCmarketwatch.com - May 12 at 12:23 AMManoj Madhavanseekingalpha.com - May 6 at 2:02 AMBiopharmaceuticals Market Size [2023-2030] | Industry Share, Revenue, Key Players, CAGR, Demand and Forecastfinance.yahoo.com - May 3 at 8:55 PMStaidson (Beijing) Biopharmaceuticals Co. Ltd.wsj.com - April 13 at 1:19 PMBiopharmaceuticals Market Growth: Worth $700Bn by 2028 Led by Monoclonal Antibodies Held Market Share of 48.42% in 2022 | The Insight Partnersfinance.yahoo.com - March 28 at 8:01 AMBiopharmaceuticals Market 2023 Analysis by Market Size, New Technology, Growth Rate, Geographical Regions, Drivers and Outlook to 2027marketwatch.com - January 29 at 12:40 PMNAVB Navidea Biopharmaceuticals, Inc.seekingalpha.com - January 25 at 12:55 PMBiopharmaceuticals Contract Manufacturing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)finance.yahoo.com - January 25 at 12:55 PMWell-Fed Analysts Stay Mum on Keryx Biopharma's Slow Drug Launchthestreet.com - September 15 at 7:41 AMKeryx (KERX) Q1 Loss Wider than Expected, Revenues Beatfinance.yahoo.com - October 26 at 5:15 AMTwitter tests notification banner for suspended and locked accountsau.finance.yahoo.com - July 29 at 10:33 PMJoey Jordison, Slipknot co-founder and longtime drummer, dies at age 46yahoo.com - July 29 at 5:32 PMWhy Starbucks (SBUX) Might Surprise This Earnings Seasonuk.finance.yahoo.com - July 28 at 7:51 PMUN: World leaders can attend annual UN meeting in personuk.finance.yahoo.com - July 27 at 11:35 PMCreekstone Farms Meats Sizzle on Yoder Smokers With New Partnershipnz.finance.yahoo.com - July 27 at 11:35 PMMidtown, Atlanta Based Innovien Solutions Continues Growth Streakau.finance.yahoo.com - July 27 at 11:35 PMJill Biden Made This Versatile Bag Sell Out, and She Just Wore It Againnz.finance.yahoo.com - July 27 at 11:35 PMIt's Your Business | More improvements on tap for Target on North Prospectyahoo.com - July 27 at 11:35 PM Get Keryx Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for KERX and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> KERX Media Mentions By Week KERX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KERX News Sentiment▼0.000.32▲Average Medical News Sentiment KERX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KERX Articles This Week▼00▲KERX Articles Average Week Get Keryx Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for KERX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: XOMA News Vanda Pharmaceuticals News Lexicon Pharmaceuticals News Verastem News Merrimack Pharmaceuticals News Rigel Pharmaceuticals News Regulus Therapeutics News Emergent BioSolutions News OPKO Health News Innoviva News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KERX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Keryx Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.